Study 1: The release of IL1a
Dermatopoietin® stimulates human Keratinocytes to express and release interleukin-1 alpha
Figure 1
Cultured keratinocytes were incubated with different concentrations of IL1 alpha (=Dermatopoietin®) for one hour, washed and re-suspended. The Figure shows the release of IL1 alpha into the medium after 1,3,24 and 48 hours.
Figure 2
In all our products Dermatopoietin® is always combined with Hexadeltine®, a hexapeptide (=HP18). Its effect is to inhibit the late response of keratinocytes by normalizing and preventing the excessive release of IL1 alpha after 24 and 48 hours
Hergestellt in der Schweiz
Natürliche Inhaltsstoffe
Wirkstoffe
Mit Dermatopoietin